Eduard Grabscheid

CFO Eduard Grabscheid sold 15,138 shares ($1.3M) via scheduled 10b5-1 plan; stock up 59.5% in 30 days

Eduard Grabscheid, CFO of JFrog Ltd, executed four separate sales totaling 15,138 shares (15.1K shares) for $1,299,573.06 ($1.3M) at a blended average price of $85.85 on June 2–3, 2026, reducing his holdings from 224,796 shares to 209,658 shares (-6.7%). This transaction is part of a pre-arranged 10b5-1 trading plan adopted on 2025-05-16, meaning it was scheduled rather than discretionary. The company posted revenue of $153,977,000.00 for the latest quarter with negative net income of $-8,267,000.00 and remains unprofitable on a full-year basis. Grabscheid's prior sales at FROG show mixed outcomes: two March 2026 sales followed by 90-day gains of +119.0% and +98.0%, while a June 2025 sale saw a 90-day loss of -6.7%, indicating variability in post-sale price movement at this ticker.

JFrog CFO Eduard Grabscheid sold 21,702 shares ($872.4K) across 2 sales; stock -43.2% from 52-week high, -29.4% in 30 days.

Eduard Grabscheid, Chief Financial Officer of JFrog Ltd, executed two separate sales totaling 21,702 shares for $872,366.01 at a blended average price of $40.20 on March 2-3, 2026, reducing his holdings by 8.5%. The sales occurred amid significant downward price momentum: the stock has declined 29.4% over 30 days and 36.9% over 90 days, trading 43.2% below its 52-week high of $68.98. JFrog remains unprofitable (net income of $-16,431,000.00 in the latest quarter) despite posting 24.1% annual revenue growth; the company's market cap stands at $4.7B. Historically, Grabscheid's prior five sales at FROG have not been well-timed at the 90-day mark (0 of 5 sales were followed by subsequent declines), suggesting his pattern at this ticker does not indicate foresight into downturns.

JFrog CFO Grabscheid sells 16,445 shares at $44.46–$45.00 for $731,571.84; prior FROG sales poorly timed; company unprofitable.

Grabscheid Eduard, CFO of JFrog Ltd, executed 2 separate sales totaling 16,445 shares (16.4K shares) for $731,571.84 ($731.6K) on 2025-08-18 at blended average price $44.49, reducing holdings by -10.3% to 143,442 shares (143.4K shares) post-transaction. His prior 4 trades at FROG show poor timing outcomes: 2 sales on 2025-06-04 both produced 30-day declines of -6.7%, and 2 sales on 2025-02-14 both produced 30-day declines of -21.9%; across FROG trades, 0 of 2 prior measurable sells were well-timed at the 90-day mark (timing pattern 0.00%). JFrog remains unprofitable (net income $-21.7M over the most recent full fiscal year) despite 22.5% annual revenue growth, a structural constraint that may contextualize insider liquidity activity. The current price of $44.65 is -1.1% from the 52-week high of $45.14, positioning this sale near recent peak valuations.

CFO Grabscheid sold 13,043 shares at $45.00 for $586,935.00; stock now at $42.75 vs 52-week high $44.55.

Eduard Grabscheid, JFrog's CFO, executed 2 separate sales totaling 13,043 shares for $586,935.00 at $45.00 per share on 2025-06-04, reducing his holdings by 7.5% to 159,887 shares. The transaction occurred near the stock's 52-week high of $44.55, and the current price of $42.75 reflects a -4.0% decline from that peak. Notably, Grabscheid's cross-ticker track record shows poor sell timing: his 2 prior open-market sells averaged a 90-day return of +0.4%, meaning the stock rose after both sales, and his 90-day well-timed rate stands at 0.00%. His same-ticker history at FROG mirrors this pattern—both prior sales on 2025-02-14 saw +0.4% 90-day returns. JFrog remains unprofitable (net income of -$18.5M in the most recent quarter) despite 22.5% annual revenue growth, and the company trades at a $4.9B market cap.

CFO Eduard Grabscheid sells 11,942 shares of FROG at $42.99, reducing stake by 6.5% to 172,406 shares held

Eduard Grabscheid, CFO of JFrog Ltd, executed 2 separate sales totaling 11,942 shares for $513,386.58 at a blended average price of $42.99 on 2025-02-14. The stock is currently trading at $39.82, below the sale prices, and JFrog remains unprofitable despite +22.5% annual revenue growth. The sale represents a modest 6.5% reduction in his post-transaction holdings of 172,406 shares, suggesting a measured approach rather than a major portfolio exit. In the 30-day and 90-day periods preceding this filing, the stock rose +21.6% and +24.7% respectively, providing context for the timing of the sale relative to recent price appreciation.